期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CD_(44)V_6与肿瘤 被引量：3

下载PDF
导出
作者 孙瑜 曲有乐
机构地区 浙江海洋学院医学院医学系
出处 《黑龙江医药科学》 2005年第5期88-90,共3页 Heilongjiang Medicine and Pharmacy
基金 浙江省教育厅科研项目(20050121) 舟山市科技局科研项目(05579)
关键词 CD44V6 肿瘤
分类号 R73-354 [医药卫生—肿瘤]
  • 相关文献

参考文献22

  • 1Polverine PJ. Cellular adhesion molecules: newly idenlified mediators of angiogenesis[J]. AM J Pathol,1996,148(2) : 1023-1029.
  • 2Fukuse T, Hirata T, Naiki H, et al. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases[J] . Cancer,1999,86(7):1174.
  • 3Wielenga V J, Heider KH, Offerhaus G J, et al. Experssion of CD44 variant proteins in human colorectal cancer is related to tumor progression[J]. Caner Res, 1993,53(20) :4754-4756.
  • 4Vinata BL, Lilly YW . Post-translational modification and expression of ankyrin-binding site in GP85(Pgp-1/CD44) and its biosynthetic precursors during T- lymphoma membrane biosynthetic precursors during T - lymphoma membrane biosynthesis[J]. J Biol Chem, 1991,266(27):17983-17989.
  • 5徐钊.CD44分子与消化道肿瘤转移和预后评估的研究进展[J].国外医学（临床生物化学与检验学分册）,1998,19(3):111-113. 被引量：34
  • 6Mulder JW, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-V6-containing CD44 proteins[J]. Lancet ,1994 , 344(8935):1470-1472.
  • 7Ropponen KM, Eskelinen MJ, Lipponen PK, et al. Expression of CD44 and variant proteins in human eoloreetal and its relevance for prognosis[J]. Scand J Gastroenterol, 1998,33(3):301-309.
  • 8姜希宏,张军,马榕.粘附分子与乳腺癌的侵袭和转移[J].国外医学（肿瘤学分册）,1998,25(2):103-105. 被引量：21
  • 9Fasano M, Sabatini MT, Wieczorek R et al. CD44 and its V6 spliced variant in lung tumors: a role in histogenesis ? [J].Cancer, 1997,80 (1):34.
  • 10Iida N ,Bourguignon LY. New CD44 splice variants associated with human breast cancers [J]. J Cell Physlol , 1995, 162 (1) :127.

二级参考文献14

  • 1刘鹏飞,吴孟超,陈汉,钱光相,傅继梁.原发性肝癌CD44v　mRNA表达与肝癌复发的关系[J].第二军医大学学报,1996,17(6):561-563. 被引量：5
  • 2[1]Kleiner DE, Stetler-Stevenson WG. Quantitative zymography:detection of picogram quantities of gelatinases[J]. Anal Biochem, 1994, 218(2): 325 - 329.
  • 3[2]Young TN, Rodriguz GC, Rinehart AR, et al. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2[J].Gynecologic Oncology, 1996, 62 ( 1 ): 89 - 99.
  • 4[3]Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusion of patients with malignant and nonmalignant disease [ J ]. Cancer, 1999, 85 ( 1 ): 178 - 187.
  • 5[4]Mori A, Arii S, Furutani M, et al. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes[J]. Gene Therapy, 2000, 7(12): 1027-1033.
  • 6[5]Zebrowski BK, Liu W, Ramirez K, et al. Markedly elevated levels of vascular endothelial growth factor in malignant ascites[J]. Ann Sury Oncol, 1999,6(4), 6:373 - 378.
  • 7[6]Hasumi Y, Mizukami H, Urabe M, et al. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer[J]. Cancer Research, 2002, 62(2):2019-2023.
  • 8[7]Peterson RM, Yu Q, Stamenkovic I, et al. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites[J]. American Journal of Pathology, 2000; 156(6): 2159 - 2167.
  • 9[8]Fishman DA, Bafetti LM, Banionis S, et al. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells[J]. Cancer, 1997, 80(3): 1457 - 1463.
  • 10[9]Macaulay VM, O'Byrne KJ, Saunders MP, et al. Phase 1 study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions[J].Clinical Cancer Research, 1999, 5 (3): 513 - 520.

共引文献77

同被引文献30

引证文献3

二级引证文献1

黑龙江医药科学
2005年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部